Skip to content

Clinical efficacy and safety of Weisanzhen (one kind of Jin's three-needle treatment) on the Intervention of Sarcopenia in the Elderly

Clinical efficacy and safety of Weisanzhen (one kind of Jin's three-needle treatment) on the Intervention of Sarcopenia in the Elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000500
Enrollment
Unknown
Registered
2024-09-28
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

control group:Health Education
Observation group:Acupuncture Therapy + Health Education

Sponsors

Hubei Provincial Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for sarcopenia; 2.Age is between 60-80 years old with stable underlying diseases; 3.Cognitive ability is normal and has some level of activity; 4.The patient and their family are informed and agree to participate in the study and the patient himself/herself voluntarily participates in the study and can cooperate with the completion of the study.

Exclusion criteria

Exclusion criteria: 1.Individuals who have implanted electronic devices or metal objects in their bodies (such as pacemakers or artificial joints); 2.Patients whose condition is worsening and researchers cannot guarantee the safety of the treatment; 3.Individuals who have a fear of needles and limb movement obstruction; 4.Individuals with a standing balance of less than level 1 or who have been bedridden for a long time; 5.Individuals with severe cardiopulmonary insufficiency mental and psychological disorders or cognitive impairment; 6.Individuals who are deemed unsuitable for participation in the study by various researchers.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;

Secondary

MeasureTime frame
Full Body Response Time Test;Measurement of Leg Latitude;Upper Limb Grip Strength Test;6-minute Walking Test;Five Repetition Sit-to-Stand Test;Lower Limb Muscle Strength Test;

Countries

China

Contacts

Public ContactXia Wenguang

Hubei Provincial Hospital of Integrated Chinese and Western Medicine

docxwg@163.com13377897278

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026